NIDA NEUROPROTEOMICS RESEARCH CENTERS (NIDA NPRCs)
The summary for the NIDA NEUROPROTEOMICS RESEARCH CENTERS (NIDA NPRCs) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIDA NEUROPROTEOMICS RESEARCH CENTERS (NIDA NPRCs): The National Institute on Drug Abuse is requesting applications for the support of Neuroproteomics Research Centers (NPRCs). These Centers should be built around scientific themes that address questions relevant to the mission of the National Institute on Drug Abuse. The Centers will support already existing neuroscience research, provide training in proteomics technologies and develop new proteomics technologies. The objective of this program is to provide technical and administrative support for proteomics Centers in order to increase the accessibility of the Centers to neuroscience researchers at institutions with a demonstrated need for such a resource, to develop new or improve existing proteomics technologies that would be applied to the analysis of tissues of the nervous system and promote sharing of information with the scientific community. While Centers should be at institutions that have extensive ongoing neurobiology research, they will not be restricted to working solely with investigators from their own institution. The objectives in establishing these Centers are to: (1) provide neurobiologists with the ability to benefit from proteomics experiments, (2) build a cadre of proteomics experts who will develop expertise in analyzing neural tissues, and (3) develop new or improve existing proteomics technologies as they relate to neurobiology or tissues of the nervous system. This announcement does not support the purchase of large pieces of equipment ($100,000 +). Investigators may seek funding from the National Center for Research Resources at the NIH for the purchase of equipment. http://www.ncrr.nih.gov/rsrch_funding.asp
Federal Grant Title: | NIDA NEUROPROTEOMICS RESEARCH CENTERS (NIDA NPRCs) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-04-004 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Oct 24, 2003 |
Posted Date: | Aug 05, 2003 |
Creation Date: | Nov 23, 2003 |
Archive Date: | Nov 23, 2003 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH
- Similar Government Grants
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...